Literature DB >> 18479275

Primary care physicians and insulin initiation: multiple barriers, lack of knowledge or both?

S Jabbour.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18479275     DOI： 10.1111/j.1742-1241.2008.01757.x

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN： 1368-5031            Impact factor:   2.503


× No keyword cloud information.
  15 in total

1.  Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Authors:  S E Inzucchi; R M Bergenstal; J B Buse; M Diamant; E Ferrannini; M Nauck; A L Peters; A Tsapas; R Wender; D R Matthews
Journal:  Diabetologia       Date:  2012-04-20       Impact factor: 10.122

2.  Diabetes and cancer: a consensus report.

Authors:  Edward Giovannucci; David M Harlan; Michael C Archer; Richard M Bergenstal; Susan M Gapstur; Laurel A Habel; Michael Pollak; Judith G Regensteiner; Douglas Yee
Journal:  Diabetes Care       Date:  2010-07       Impact factor: 19.112

Review 3.  Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Authors:  Silvio E Inzucchi; Richard M Bergenstal; John B Buse; Michaela Diamant; Ele Ferrannini; Michael Nauck; Anne L Peters; Apostolos Tsapas; Richard Wender; David R Matthews
Journal:  Diabetes Care       Date:  2012-04-19       Impact factor: 19.112

4.  Liraglutide as add-on therapy to insulin in type 2 diabetes mellitus: a retrospective, observational study from a daily clinical practice setting in Switzerland.

Authors:  Christof Lipowsky; Lisa Sze; Ina Krull; Michael Brändle
Journal:  Diabetes Ther       Date:  2015-01-10       Impact factor: 2.945

Review 5.  The association between type 2 diabetes mellitus and women cancer: the epidemiological evidences and putative mechanisms.

Authors:  Kyong Hye Joung; Jae-Wook Jeong; Bon Jeong Ku
Journal:  Biomed Res Int       Date:  2015-03-19       Impact factor: 3.411

6.  Engaging GPs in insulin therapy initiation: a qualitative study evaluating a support program in the Belgian context.

Authors:  Patricia Sunaert; Sara Willems; Luc Feyen; Hilde Bastiaens; Jan De Maeseneer; Lut Jenkins; Frank Nobels; Emmanuel Samyn; Marie Vandekerckhove; Johan Wens; An De Sutter
Journal:  BMC Fam Pract       Date:  2014-08-21       Impact factor: 2.497

7.  Comparison of insulin degludec with insulin glargine in insulin-naive subjects with Type 2 diabetes: a 2-year randomized, treat-to-target trial.

Authors:  H W Rodbard; B Cariou; B Zinman; Y Handelsman; A Philis-Tsimikas; T V Skjøth; A Rana; C Mathieu
Journal:  Diabet Med       Date:  2013-09-30       Impact factor: 4.359

8.  Current therapeutic agents and anesthetic considerations for diabetes mellitus.

Authors:  Hyoseok Kang
Journal:  Korean J Anesthesiol       Date:  2012-09-14

9.  Diabetes and risk of cancer.

Authors:  Samy L Habib; Maciej Rojna
Journal:  ISRN Oncol       Date:  2013-02-07

10.  Canagliflozin, a sodium glucose co-transporter 2 inhibitor, improves model-based indices of beta cell function in patients with type 2 diabetes.

Authors:  David Polidori; Andrea Mari; Ele Ferrannini
Journal:  Diabetologia       Date:  2014-03-01       Impact factor: 10.122
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.